AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract HHSN272201500014CSPERO THERAPEUTICS, INC.
Overview
Award facts
- Net obligations
- $5.92M
- $5,923,719of $9.39M potential value
- Outlays (paid to date)
- $0
- $0 paid of $5.92M obligated$0
- Period of performance
- Jun 30, 2015 to Jun 15, 2021
- Ended
- Modifications
- 19
- Latest action Apr 8, 2022
- Contract type
- Definitive contract
- PIID HHSN272201500014C
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF - "DEVELOPMENT OF A SECOND GENERATION POLYMYXIN FOR THERAPY OF MDR GRAM-NEGATIVE INFECTIONS"
Dates and value
- Award date
- Signed on Jun 30, 2015
- Potential end of performance
- Jun 14, 2021
- Current value
- $5,923,719Base and exercised options
- Potential value (if all options are exercised)
- $9,391,176
Obligations by fiscal year of action
- FY2022: -$4,302 (de-obligation)
- FY2019: $210,895
- FY2018: $571,132
- FY2017: $2,015,511
- FY2016: $1,634,580
- FY2015: $1,495,903
Total across 6 fiscal years: $5,923,719
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 8, 2022. View on USAspending · Recipient on SAM.gov
Recipient
LocationCAMBRIDGE, MA
UEINX34PL7NZW24
CAGE code7SK81
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companySPERO THERAPEUTICS, INC.
Business types and certifications
Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- 02139-3309 United Kingdom
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 25
Solicitation and notices
- Solicitation ID
- NIHAI2014007(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jun 30, 2015Base obligation at award: $1,495,903
- Latest action
- Apr 8, 2022 — Other administrative actionModification P00019; obligation change -$4,302; administrative: no change in scope or value
- Latest substantive action
- Jun 3, 2020 — Change orderModification P00015
- Actions by type
- Base award1
- Other administrative action8
- Supplemental agreement (within scope)7
- Change order2
- Option exercised1
- Novation (contract transferred)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$4,302
- Latest action: change in base and all options
- -$4,302
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- Yes
Place and origin
- Domestic or foreign entity
- Foreign-owned business not incorporated in the U.S.D
- Country of product or service origin
- United kingdomGBR
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 20
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2017/2017-0885-000
- 075-2018/2018-0885-000
- 075-2019/2019-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression